Latest Breaking News On - Christopher cabell - Page 1 : comparemela.com

Zura Bio Limited , a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, today announced two abstracts were accepted and.

Krung thep mahanakhonJackson cabellSomeit sidhuChristopher cabellZura bioJavier cote sierraMichael howellBrandon walshWorld allergy congressZura bio limited nasdaqZura bio limitedChief scientific officerTranslational scienceKarl deaconPrivate securities litigation reform act